{
    "title": "AstraZeneca pilots diabetes drug as potential COVID-19 treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8248441/AstraZeneca-tests-diabetes-drug-possible-COVID-19-treatment.html",
    "date": "2020-04-23",
    "keywords": [
        "heart",
        "covid19",
        "trial",
        "disease",
        "astrazeneca",
        "risk",
        "drug",
        "treatment",
        "kidney",
        "coronavirus",
        "study",
        "death",
        "failure",
        "cancer",
        "therapy",
        "httpswwwastrazenecacommediacentrepressreleases2020astrazenecaandsaintlukesmidamericaheartinstituteinitiatephaseiiidare19trialwithfarxigaincovid19patientshtml",
        "thursday",
        "fastspreading",
        "virus",
        "outbreak",
        "respiratory",
        "illness",
        "application",
        "vp",
        "company",
        "research",
        "calquence",
        "glaxosmithkline",
        "cambridge",
        "university",
        "laboratory",
        "astrazenecas",
        "partnership",
        "saint",
        "institute",
        "drugmaker",
        "goal",
        "progression",
        "submission",
        "farxiga",
        "type2",
        "part",
        "sglt2inhibitor",
        "class",
        "medication",
        "blood",
        "sugar",
        "urine",
        "promise",
        "condition",
        "johnson",
        "co",
        "boehringer",
        "jardiance",
        "lung",
        "report",
        "httpswwwreuterscomarticleushealthcoronavirususastudydiabeteslungandheartdiseasecommoninuscoronaviruspatientscdciduskbn21i3hm",
        "month",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "chakrabarty",
        "sriraj",
        "kalluvila",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}